GNPX
GNPX
NASDAQ · Biotechnology

Genprex Inc

$0.84
-0.02 (-2.88%)
As of May 16, 2:34 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +3,206.6% upside
Low Target $20.34
Average Target $27.66
High Target $35.38
Current Price $0.84
Current
$0.84
Target
$27.66
$20.34 $27.66 avg $35.38
Scenario Analysis
Bear Case
$20.34
2,331.6%
Low target
Base Case
$27.66
+3,206.6%
Avg target
Bull Case
$35.38
+4,129.5%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$55.00
-98.5% from high
52-Week Low
$0.81
+3.0% from low
Target vs 52W High
$27.66
-49.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.6%